- 询价
- Nebulabio
- NBL-286633
- 2025年09月19日
企业认证
相关产品推荐更多 >
重组人RAD18蛋白 | Recombinant Human RAD18 Protein, 12-99aa, His-tag, GST-tag
询价重组人PHOX2B蛋白 | Recombinant Human PHOX2B Protein, 106-173aa, His-tag, SUMO-tag
询价
重组人JAG1蛋白 | Recombinant Human JAG1, Fc-tag
询价重组人Polypeptide GalNAc transferase 3蛋白 | Recombinant Human Polypeptide GalNAc transferase 3, His-tag
询价重组人RGS17蛋白 | Recombinant Human RGS17 Protein, 74-210aa, His-tag
询价
万千商家帮你免费找货
0 人在求购买到急需产品
- 详细信息
- 文献和实验
- 技术资料
- 保存条件：
见COA
- 保质期：
见COA
- 库存：
大量
- 供应商：
北京辰辉创聚生物技术有限公司
- 规格：
100ug; 500ug; 1mg; Bulk
| 产品信息
品名：NebuSelect™ Native Human Complement C5
别名：S100; S100A1
货号：NBL-286633
品牌：Nebulabio
规格：100ug; 500ug; 1mg; Bulk
| 产品描述
NebuSelect™ Native Human Complement C5(CAT#NBL-286633) is a native protein, purified from human plasma. The purity is ≥ 95%.
| 产品属性
Species:Human
Expression System:Native Protein
Molecular Weight: 190 kDa
Target Name:Complement C5
Purity:≥ 95%
Formulation:See COA
Endotoxin:＜0.1EU/ug(LAL Method)
Storage: Short term 4℃; Long term -20℃. Avoid repeated freeze-thaw cycles.
For Research Use Only!
To get more information, please contact us freely.
风险提示：丁香通仅作为第三方平台，为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全，合理判断，谨慎选购商品，商家和用户对交易行为负责。对于医疗器械类产品，请先查证核实企业经营资质和医疗器械产品注册证情况。
文献和实验Purification of Human Complement Protein C5
Complement C5 is cleaved by proteolysis in the terminal phase of complement activation generating the pro-inflammatory C5a and membrane attack complex nucleator C5b. Whereas purification of its paralogues C3 and C4 from plasma is relatively
Immunochemical Measurement of Complement Components and Activation Products
convertases or the terminal complement complex (TCC). The latter can be generated on biological membranes or in the fluid phase (C5b-9). Activation-dependent changes on molecules or complexes can be revealed by the disappearance of native-restricted epitopes
Crossmatching by Complement-Dependent Lymphocytotoxicity
tests pre-transplant. The standard CDC crossmatch detects IgG1, IgG3, and IgM antibody, i.e. complement fixing, bound to the native viable cell surface of lymphocytes. The crossmatch can be enhanced with the addition of anti-human-globulin to detect non
技术资料暂无技术资料 索取技术资料
